As we celebrate National Women's History Month, recognizing the social, economic, cultural, and political achievements of women – strides made recently have elevated women to new heights, but a Rutgers University‒Camden scholar says there is a long way to go to overcome gender equality hurdles.
Despite strong evidence that medication is the most effective treatment for opioid use disorder (OUD), adolescents and most adults who might benefit from OUD treatment report no medication use, according to a study by researchers at the Rutgers School of Public Health and Columbia University Mailman School of Public Health.
A Rutgers researcher has received a $1.9 million award from the National Institutes of Health (NIH) to investigate the role of an enzyme in the gut and its potential as a therapy to help lower lipid levels in the blood.
Rutgers Office for Research welcomes Hila Feldman Berger as assistant vice president of research regulatory affairs, starting March 22, 2022. Berger joins Rutgers from Montclair State University where she served as director of research compliance and regulatory programs.
The Invisible Extinction chronicles the pioneering work of globetrotting microbiome researchers Martin Blaser and Maria Gloria Dominguez-Bello.
An antiviral drug used to treat SARS-CoV-2 remains effective against the newest variants of the evolving virus, according to Rutgers researchers.
People with chronic kidney disease over the age of 65 who are not candidates for transplant should be given the opportunity to not decide to begin dialysis in order to ensure informed decision-making, according to a new Rutgers paper.
When Rutgers—University Newark researcher Jamelia Harris set out to study an educational system that disproportionately punishes and criminalizes Black girls, she relied on the girls themselves to help find answers.
New research may help scientists locate immature cells in the central nervous system that could shed light on the causes of neurodegenerative diseases like multiple sclerosis—an autoimmune disease that affects the brain and nervous system—and allow for the development of better therapeutic treatments.
A high number of teens and young adults with an overdose involving a benzodiazepine (BZD), like Xanax, or psychostimulant, like Adderall, have a recent medical prescription for a BZD or stimulant, according to Rutgers researchers who say physicians need to weigh the risks and benefits of these medications more closely.
A Rutgers researcher’s new formula with Investigational New Drug (IND) status has successfully alleviated a patient’s long-term severe gastrointestinal (GI) illness associated with post-acute COVID-19 syndrome, or long-haul COVID, in a recent study.
